Occurrence of aflatoxins in some medicinal plants stored under different conditions by Kostik, Vesna
IOSR Journal Of Pharmacy 
(e)-ISSN: 2250-3013, (p)-ISSN: 2319-4219 
www.iosrphr.org Volume 5, Issue 2 (February 2015), PP. 38-44 
38 
Occurrence of aflatoxins in some medicinal plants stored under 
different conditions 
 
Vesna Kostik  
Institute of Public Health of Republic of Macedonia, 50 Divizija No. 6 , 1000 Skopje, Republic of Macedonia, 
Assistant professor  
 
Abstract : Medicinal plants are widely used as home remedies and raw materials for the pharmaceutical 
industries. During harvesting, handling, storage and distribution, medicinal plants are subjected to 
contamination by various fungi, which may be responsible for spoilage and production of mycotoxins. The 
increasing consumption of medicinal plants has made their use a public health problem due to the lack of 
effective surveillance of the use, efficacy, toxicity and quality of these natural products. 
The aim of this study was to determine the content of aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin  G1 
(AFG1),  aflatoxin  G2 (AFG2) and the sum of total aflatoxins (AFs) in medicinal plants which were stored in 
storehouses with controlled macro-environment such as humidity, temperature; modified macro-environment of 
50% CO2, 30% O2 and 20% N2 and in storehouses with air at 25 
0
C and relative humidity between 70% and 
80%. The results of this study revealed that the content of AFs was the lowest in medicinal plants which were 
stored in modified macro-environment. This implies the necessity of continuous monitoring of the macro-
environmental condition during the storage.  
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I. INTRODUCTION 
Mycotoxins are toxic secondary metabolites produced by moulds such as Aspergillus, Penicillium, 
Fusarium and Alternaria [1]. Mycotoxins can be defined as ‘‘fungal metabolites that when ingested, inhaled or 
absorbed through the skin cause illness or human and animal death’’ [2]. Mycotoxins cause variety of toxic 
effects. They are carcinogenic, neurotoxic, teratogenic and immunotoxic [3].  
 Aflatoxins (AFs) are a class of mycotoxins produced mainly by toxigenic strains of 
Aspergillus flavus and Aspergillus parasiticus and rarely by Aspergillus nomius which can grow on various 
kinds of foods, beverages and medicinal plants. Aflatoxins are the most important human mycotoxins and are 
among the most toxic mycotoxins [4]. There are nearly 20 different types of aflatoxins of which the four major 
ones are aflatoxins B1, B2, G1 and G2. Aflatoxin B1 (AFB1) and aflatoxin B2 (AFB2) are produced by Aspergillus 
flavus, while all four isoforms (B1, B2, G1, and G2) are produced by Aspergillus parasiticus [5]. Aflatoxin B1 is 
the most toxic of the aflatoxins and most potent naturally occurring hepatic carcinogen [6]. Aflatoxins are 
amongst the most powerful mutagens and carcinogens known. The International Agency of Research on Cancer 
(IARC) has classified AFs as Group 1 human carcinogen [7]. Aflatoxins and hepatitis B virus (HBV) infection 
synergistically develop approximately thirty-fold higher hepatocellular carcinoma risk in aflatoxin-exposed, 
HBV-positive individuals, as compared to HBV-negative persons [8]. Other toxic effects of aflatoxins include 
genotoxicity, teratogenicity and immunosuppressive activity. Aflatoxin B1 letal dose 50 (LD50) values for most 
animal species ranges from 1 to 50 mg/kg body weight [9]. 
The aflatoxin contamination of herbal drugs is controlled by legal limits. Maximum limits of 2 μg/kg 
for AFB1 and 4 μg/kg for total aflatoxins in herbal drugs have been set by the European Pharmacopoeia [10]. 
However due to the fact that most herbs are processed before consumption, higher maximum limits of 5 μg/kg 
and 10 μg/kg for AFB1 and total aflatoxins, respectively, have been proposed [11]. 
Medicinal plants are frequently contaminated with toxic fungi originating in the soil. During 
harvesting, handling, storage and distribution, these plants are subjected to contamination by various fungi, 
which may be responsible for spoilage and production of mycotoxins [12]. The condition is serious especially in 
developing countries, where there are poor production practices [i.e., good agricultural practices (GAP) and 
good harvesting practices (GHP) are inadequate]. Moreover, the poor conditions of storage and transportation 
contribute to fungal contamination and increase the risk of mycotoxin production [13].  
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The Republic of Macedonia has the exceptional geographical position with excellent climate, as well as 
relief, with a large number of sunny days, which allows growing of more than 3,000 species of higher plants of 
which 1,000 have medical properties. Nowadays, the consumption of medicinal herbs as home remedies and 
raw materials for the pharmaceutical industries is increasing. In order to monitor the influence of storage 
conditions safety of medical plants in respect of aflatoxins contamination, a pilot study was conducted. The aim 
of this study was to investigate the occurrence and concentrations of aflatoxins residues in some medicinal 
plants from domestic producers, which are stored in storehouses with controlled ambient conditions (humidity, 
temperature, the content of O2, CO2 and N2) and medicinal plants which are stored in air at 25 °C and 80% 
relative humidity.  
II. MATERIALS AND METHODS 
2.1. Sampling 
During 2014, a total of 176 samples of ten different medicinal plants: Matricaria chamomilla L. 
(flowers), Tilia parvifolia L. (flowers), Verbascum thapsus L. (flowers), Taraxacum officinale L. (roots), 
Herniaria glabra L. (aerial parts), Hibiscus esculentus L. (leaves), Mentha piperita L. (aerial parts), Achillea 
milefolium L. (aerial parts), Rosa canina L. (rose hips) and Sambucus nigra L.(flowers) were tested to detect the 
presence of residues of the alflatoxins AFB1, AFB2, AFG1, AFG2 and the sum of total aflatoxins (AF). All plants 
were cultivated in the Republic of Macedonia. The samples were obtained from storehouse with air at 22 °C and  
relative humidity below 40% (S1), storehouse with modified atmosphere of 50%, CO2, 30% O2, and 20 % N2 
(S2) and storehouses with air at 25 °C and relative humidity between 70% and 80% (S2 and S3).  Blank samples 
of Matricaria chamomilla L. and Achillea milefolium L. were purchased from a local organic producer. Blank 
samples were used for the fortification experiment. 
 
2.2. Reagents and standards 
HPLC reagents (methanol, acetonitrile, water) and chemicals (benzene, KBr, NaCl, HNO3) were 
purchased from Merck (Darmstadt, Germany). For clean-up purification immunoaffinity columns Aflaprep (R-
Biopharm Rhône, Glasgow, Scotland) were used. Purified water was delivered by the Millipore water 
purification device Milli-Q Gradient A10 (Bedford, USA). 
Reference pure standards of each individual aflatoxin were obtained from Sigma Aldrich/Fluka/Riedel-
de-Haen (Zwijndrecht, The Netherlands). Stock standard solution mixture of aflatoxins above indicated was 
prepared in chloroform at a concentration of 10 μg/mL. From this, a dilution with a final concentration of 0.10 
μg/mL solution was used for calibration standards purposes. Portions of 125, 250, 500, 750 and 1000 μL from 
this last standard were evaporated in 250 mL volumetric flasks, afterwards re-dissolved with 75 mL of methanol 
and filled up with water. The following concentrations were achieved: 0.05, 0.10, 0.20, 0.30, 0.40 in ng/mL. For 
recovery experiments, 5 mL of a 0.40 μg/mL total aflatoxins standard solution was used to fortify 1 kg of blank 
matrix the day prior to analysis, resulting in a level of fortification of 2 μg/kg. 
 
2.3. HPLC equipment and reverse phase conditions 
HPLC analysis was performed with Perkin Elmer (PE) chromatographic system equipped with binary 
pump (PE LC-250), manual injector (PE Rheodyne 7125) and fluorescence detector (PE LC-240). Aflatoxins 
were separated on Supelco column (250 mm x 4.6 mm, 5mm) at room temperature. The mobile phase was a 
mixture of water: acetonitrile: methanol (600:50:350, V/V/V) with addition of 119 mg KBr and 350 mL 4N 
HNO3. The mobile phase was degasified in the ultrasonic bath before use. The flow rate was 1 mL/min and the 
injection volume was 100 mL. The detection was carried out at excitation of 360 nm and emission of 440 nm.  
 
2.4. Sample preparation and clean up 
The extraction and purification of aflatoxins from medicinal plant samples was done according to 
AOAC method [14]. High performance liquid chromatography (HPLC) with fluorescence detector (FlD)   was 
performed according to ISO standard [15]. 25 g of tested sample with addition of 5 g NaCl and 125 mL 70% 
(V/V) methanol was mixed in a blender jar for 2 min at high speed. The mixture was filtered through a fluted 
filter paper. 30 mL of purified water was added to a 15 ml of filtrate and filtered again through microfiber filter 
paper. 15 mL of the second filtrate was quantitatively passed through the immunoaffinity column at flow rate of 
1mL/min. The column was washed with 10 mL of water. Aflatoxins were eluted with 1 mL of methanol in an 
amber vial at flow rate of 1 mL/min. The elution step was repeated one more time with 1 mL of water. Then, 
100 mL of methanol-water solution was applied to HPLC-FlD system, followed by derivatization with bromine 
in Kobra cell (R-Biopharm Rhône).  
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2.5. Statistical analysis 
The results were expressed as the mean values and standard deviation. Statistical analysis was 
performed by analysis of variance (ANOVA) and included the Tukey´s test to evaluate significant differences 
amongthe means (p < 0.05). 
 
III. RESULTS AND DISCUSSION 
The limit of detection (LOD) and the limit of quantification (LOQ) were calculated according to the 
formulas LOD = 3.3 · standard deviation (SD)/slope and LOQ = 10 · SD/slope. The computed values for all the 
tested AFs are shown in Table 1.  
 
Table 1. Limit of detection (LOD) and limit of quantification (LOQ) obtained for the tested   aflatoxins 
Aflatoxin LOD (μg/kg) LOQ (μg/kg) 
AFB1 0.03 0.1 
AFB2 0.01 0.04 
AFG1 0.09 0.3 
AFG2 0.06 0.2 
Total AFs 0.21 0.7 
 
Representative chromatograms for AFs separation with HPLC – FlD method are shown in Fig. 1 and 
Fig. 2, respectively. 
 
 
   Figure 1. Chromatogram of standard solution of AFB1, AFB2, AFG1, AFG2 at 0.3 μg/L  (methanol:water) 
 
 
 
   Figure 2. Chromatogram of the extract of the M. chamomilla sample  
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The content of aflatoxins found in the tested samples of medicinal plants is reported in Table 2. 
According to the obtained results 93.75%, 81.80% and 29% of all the tested samples were contaminated with 
AFB1, AFB2 and AFG1 (Fig. 3) with the mean concentration of 3.1 μg/kg, 0.84 μg/kg and 0.59 μg/kg, 
respectively (Table 2). The percentage of tested samples that contained Afs below the calculated LOQ was 
found in 4% for AFB1, 16% for AFB2, 75% for AFG1 and 2% for total AFs (Fig. 4). Interestingly, no one sample 
was contaminated with AFG2, which might be due to the greater susceptibility of medicinal plants towards Asp. 
flavus than towards Asp. Parasiticus.  
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Figure 3. Percentage of contaminated samples with AFs 
 
 
Figure 4. Percentage of samples with the content of AFs below MAC 
 
In their study Roy and Chourasia found out that 81.1% of tested medicinal plants obtained from local 
Indian storehouses were contaminated with aflatoxins [16]. Our findings for AFs content in medicinal plants 
were  in line with those reported by Roy and Kumari, 1991 [17], but far below the results obtained by Yang et al 
[18] and Liu et al. [11]. Namely, in their investigations of the AFs content in the traditional Chinese medicinal 
herb samples, they demonstrated the occurrence of AFs up to 32 μg/kg and 290.8 μg/kg, respectively. However 
in another study only 5.2% medicinal herbs samples from China were confirmed positive for aflatoxins [19]. 
Aflatoxin contamination in medicinal plants has been reported in the study conducted by Selim et al. [20]. They 
revealed that in Egypt, 29% of the 31 samples of herbs and medicinal plants were determined to contain AFB1 
with a mean concentration of 49 μg/kg. Contrary in another study in Egypt, different samples of medicinal 
plants, showing presence of moulds (Aspergillus, Penicillium, Fusarium etc.), were tested to be free of 
aflatoxins [21].  
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High moisture content, relative humidity, temperature and environment rich in oxygen (O2) are 
designated as the main factors for contamination of agricultural commodities with Afs [22]. The growth of fungi 
which produced AFs is directly related to the conditions of their storage, transport and commercialization. But, 
we couldn’t find any data in the literature for correlation between the occurrence of AFs in medicinal plants and 
the content of moisture, temperature and oxygen during their storage. Therefore, in our study we investigated 
the content of AFs in medicinal plants which were stored under different atmospheric conditions as described 
above.    
The results of our study revealed that the concentrations of AFB1 in the all the tested samples from 
storehouses S3 and S4 were over the established maximum allowable concentration (MAC) of 2 μg/kg, ranging 
from 2.88 μg/kg to 7.45 μg/kg. At the 0.05 level of significance, the analysis of variance revealed that the 
population means for AFB1 content showed a significant difference (p<0.05) between the analyzed samples of 
medicinal plants from storehouses S1 and S2 vs. the samples from the storehouses S3 and S4. The content of 
AFB2 was also higher in all the tested samples from the storehouses S3 and S4 in comparison with the results 
obtained for the samples from the storehouses S1 and S2 (p<0.05). Significant differences at the 0.05 level were 
also observed for the total AFs content between the samples from the storehouses S1 and S2 compared with the 
samples from the storehouses S3 and S4. Namely, the content of total AFs was found to be higher in all the 
tested the samples from the storehouses S3 and S4 in the range from 3.47 μg/kg to 9.69 μg/kg.   
The concentrations of aflatoxins in the samples from storehouses S1 and S2 were all below MAC, in 
the range from <0.1 μg/kg to 1.94 μg/kg (AFB1), from <0.04 μg/kg to 0.45 μg/kg (AFB2) and from <0.7 μg/kg 
to 2.17 μg/kg (total AFs). Low content of AFs in the samples from the storehouses S1 and S2 is due to the lower 
content of moisture, lower temperature and modified atmosphere in storage (macro-environment). But, in spite 
of the low AFs content in the samples from the both storehouses, the analysis of variance at the 0.05 level of 
significance showed significant differences (Fig. 5) for the AFB1 content (M. chamomile, V. Thapsus, H. glabra, 
H. esculentus, R. canina and S. nigra); AFB2 content (M. chamomile, V. Thapsus, H. esculentus and S. nigra) 
and total AFs content (M. chamomile, V. Thapsus, H. glabra, H. esculentus, R. canina and S. nigra), which 
might be due to the natural contamination with AFs. 
 
 
Figure 5.  Statistical data for AFs content between the samples from S1 and S2 
 
IV. CONCLUSION 
The content of aflatoxins found in the tested samples of medicinal plants is directly influenced by the 
macro-environmental conditions during the storage. The lowest AFs content was observed in all tested samples 
which were stored under modified macro-environment which were consisted of 50% CO2, 30% O2 and 20% N2. 
Humidity and temperature also have impact on the AFs occurrence in tested samples. Due to the importance and 
the widespread usage of the medicinal plants, special attention should be taken in terms of the conditions of their 
storage, as well as, during transportation and commercialization. Continuous surveillance of the AFs content 
also should be performed in the final products which are sold in the market.   
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